Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,560 | 58,523 | 84,477 | 31,269 | 44,948 |
| Marketable Securities | 398,233 | 346,835 | 222,838 | 244,693 | 186,697 |
| Receivables | 21,957 | 22,725 | 26,684 | 19,928 | 22,405 |
| Inventories | 4,817 | 4,927 | 5,084 | 5,424 | 5,462 |
| TOTAL | $463,493 | $438,333 | $344,776 | $307,358 | $267,310 |
| Non-Current Assets | |||||
| PPE Net | 1,311 | 619 | 880 | 1,050 | 1,227 |
| Investments And Advances | 15,425 | 4,200 | 41,690 | 39,352 | 35,250 |
| Other Non-Current Assets | 53,896 | 54,671 | 58,148 | 64,552 | 63,235 |
| TOTAL | $70,632 | $59,490 | $100,718 | $104,954 | $99,712 |
| Total Assets | $534,125 | $497,823 | $445,494 | $412,312 | $367,022 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,510 | 6,304 | 4,976 | 7,537 | 5,937 |
| Accrued Expenses | 15,532 | 33,920 | 7,938 | 6,477 | 4,121 |
| TOTAL | $43,048 | $42,243 | $34,075 | $38,841 | $32,396 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 997 | 1,486 | 1,541 | 1,903 | 0 |
| TOTAL | $1,397 | $1,882 | $1,930 | $2,289 | $250 |
| Total Liabilities | $44,445 | $44,125 | $36,005 | $41,130 | $32,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,173 | 115,558 | 114,602 | 114,595 | 114,281 |
| Common Shares | 121 | 121 | 120 | 120 | 119 |
| Retained earnings | 56,462 | 34,837 | 6,510 | -23,555 | -52,936 |
| Other shareholders' equity | 608 | 1,026 | 331 | 557 | 582 |
| TOTAL | $489,680 | $453,698 | $409,489 | $371,182 | $334,376 |
| Total Liabilities And Equity | $534,125 | $497,823 | $445,494 | $412,312 | $367,022 |